PROBLEMS OF ANTIBACTERIAL THERAPY FOR CHILDHOOD TONSILLOPHARYNGITIS AND POSSIBILITIES FOR THEIR SOLUTION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Tonsillopharyngitis is a common disease in children who are given antibiotics in most cases. Three main problems of antibacterial therapy for tonsillopharyngitis have been singled out, which are: 1. To define indications for the use of an antibiotic (The disease is caused more frequently by viruses, less frequently by group A β-hemolytic streptococcus (GAβHS) and other bacteria. It is necessary to verify the streptococcal etiology that requires an antibiotic. For this, rapid diagnosis of GAβHS should be widely put into practice). 2. To choose an antibiotic. GAβHS is always susceptible to penicillins, but the latter are not always effective (On choosing a drug, it is necessary to combine its efficacy and safety for the patient). 3. To achieve GAβHS eradication (a 10-day course of therapy with most antibiotics is recommended, which the patients are rarely compliant with. It is expedient to give preference to high-compliance therapy). The oral third-generation cephalosporin ceftibuten that is highly effective, including when used as short-term courses, shows promise in the treatment of tonsillopharyngitis.

全文:

受限制的访问

作者简介

I. DRONOV

I.M. Sechenov First Moscow State Medical University

Email: dronow@yandex.ru

U. MALYAVINA

I.M. Sechenov First Moscow State Medical University

参考

  1. Nash D.R., Harman J., Wald E.R. et al. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch. Pediat. Adolesc. Med. 2002; 156 (11): 1114—1119.
  2. Bisno A.L. Acute pharyngitis. N. Engl. J. Med. 2001; 344 (3): 205—211.
  3. Linder J.A., Bates D. W, Lee G.M. et al. Antibiotic treatment of children with sore throat. JAMA. 2005; 294 (18): 2315—2322.
  4. Schroeder B.M. Diagnosis and management of group A streptococcal pharyngitis. Am. Fam. Physician. 2003; 67 (4): 883—884.
  5. Ebell M.H. Epstein-Barr virus infectious mononucleosis. Am. Fam. Physician. 2004; 70 (7): 1279—1287.
  6. Rammelkamp C.H., Wannamaker L.W., Denny F.W. The epidemiology and prevention of rheumatic fever. Bull. N.Y. Acad. Med. 1952: 28 (5): 321—334.
  7. Del Mar C.B., Glasziou P.P., Spinks A.B. Antibiotics for sore throat. Cochrane Database Syst. Rev. 2006; 18 (4): CD000023.
  8. Баранов А.А., Богомильский М.Р., Волков И.К. и др. Применение антибиотиков у детей в амбулаторной практике: Практические рекомендации. КМАХ 2007; 9 (3): 200—210.
  9. Козлов С.Н., Страчунский Л.С., Рачина С.А. Фармакотерапия острого тонзиллофарингита в амбулаторной практике: результаты многоцентрового фармакоэпидемиологического исследования. Тер. арх. 2004; 76 (5): 45—51.
  10. Андреева И.В. Фармакоэпидемиология антибактериальных препаратов у населения: Автореф. дис.. канд. мед. наук. Смоленск, 2003.
  11. Шпынев К.В., Кречиков В.А. Современные подходы к диагностике стрептококкового фарингита. КМАХ 2007; 9 (1): 20—33.
  12. Насонова В.А., Белов Б.С., Страчунский Л.С. и др. Антибактериальная терапия стрептококкового тонзиллита и фарингита. КМАХ 1999; 1: 78—82.
  13. Gerber M.A., Baltimore R.S., Eaton C.B. et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2008; 119: 1541—1551.
  14. Portier H., Grappin M., Chavanet P. New strategies for angina case management in France. Bull. Acad. Natl. Med. 2003; 187 (6): 1107—1116.
  15. Maltezou H.C., Tsagris V., Antoniadou A. et al. Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription. J. Antimicrob. Chemother. 2008; 62 (6): 1407—1412.
  16. В России зарегистрирован экспресс-тест Streptatest для диагностики стрептококкового тонзиллофарингита — сайт «Антибиотики и антимикробная терапия» — URL: antibiotic.ru/index.php?article=1995 (опубликовано 11.08.2010 г.).
  17. Шпынев К.В., Кречикова О.И., Кречиков В.А. и др. Streptococcus pyogenes: характеристика микроорганизма, выделение, идентификация и определение чувствительности к антибактериальным препаратам. КМАХ 2007; 9 (2): 104—119.
  18. Kozlov R., Sivaja O. Antimicrobial resistance of S. pyogenes in Russia: results of prospective multicentre study PEHASus. In: 17th European Congress of clinical microbiology and infectious diseases ICC. Munich, Germany. 31 March — 04 April 2007. Abstract 1733_255.
  19. Bisno A.L., Gerber M.A., Gwaltney J.M. Jr. et al. Practice guidelines for the diagnosis and managementof group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin. Infect. Dis. 2002; 35 (2): 113—125.
  20. Gastanaduy A.S., Kaplan E.L., Huwe B.B. et al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 6 (2): 498—502.
  21. Pichichero M.E., Marsocci S.M., Murphy M.L. et al. Incidence of streptococcal carriers in private pediatric practice. Arch. Pediatr. Adolesc. Med. 1999: 153 (6): 624—628.
  22. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev. Infect. Dis. 1984; 6 (5): 601—607.
  23. Pichichero M.E. Empiric antibiotic selection criteria for respiratory infections in pediatric practice. Pediatr. Infect. Dis. J. 1997; 16 (Suppl. 3): 60—64.
  24. Pichichero M.E. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115 (4): 1048—1057.
  25. Brook I., Gober A.E. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta. Paediatr. 2008; 97 (2): 193—195.
  26. Roos K., Grahn E., Holm S.E. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand. J. Infect. Dis. 1986; 18 (4): 313—319.
  27. Страчунский Л.С., Козлов С.Н. Современная антимикробная химиотерапия: Руководство для врачей. М.: Боргес, 2002.
  28. Van der Linden P.D., van der Lei J., Vlug A.E. et al. Skin reactions to antibacterial agents in general practice. J. Clin. Epidemiol. 1998; 51 (8): 703—708.
  29. Geyman J.P., Erickson S. The ampicillin rash as a diagnostic and management problem: case reports and literature review. J. Fam. Pract. 1978; 7 (3): 493—496.
  30. Gonzalez-Delgado P., Blanes M., Soriano V. et al. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol. Immunopathol. (Madr.) 2006; 34 (2): 76—78.
  31. Brook I., Foote P.A. Effect of penicillin or cefprozil therapy on tonsillar flora. J. Antimicrob. Chemother. 1997; 40 (5): 725—728.
  32. Brook I., Foote P.A. Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora. Antimicrob. Agents Chemother. 2005; 49 (11): 4787—4788.
  33. Casey J.R., Pichichero M.E. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004; 113 (4): 866—882.
  34. Справочник по антимикробной терапии / Под ред. Л.С. Страчунского. Смоленск: МАКМАХ, 2006.
  35. Pichichero M.E., Mclinn S.E., Gooch W.M. 3rd et al. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group. Pediatr. Infect. Dis. J. 1995; 14 (Suppl. 7): 102—107.
  36. Pichichero M.E. The importance of bacteriologic eradication in the treatment of group A streptococcal tonsillopharyngitis. Clin. Pediatr. 2009; 46: 3—16.
  37. Bergman A.B., Werner R.J. Failure of children to receive penicillin by mouth. Engl. J. Med. 1963; 268: 1334—1338.
  38. Charney E., Bynum R., Eldredge D. et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics 1967; 40 (2): 188—195.
  39. Green J.L., Ray S.P., Charney E. Recurrence rate of streptococcal pharyngitis related to oral penicillin. J. Pediatr. 1969; 75 (2): 292—294.
  40. Brook I. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens. Paediatr. Drugs. 2002; 4 (11): 747—754.
  41. Altamimi S., Khalil A., Khalaiwi K.A. et al. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst. Rev. 2009; 21 (1): CD004872.
  42. Adam D., Scholz H., Helmerking M. Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis. Fortschr. Med. Orig. 2001; 119 (Suppl. 2): 63—70.
  43. Boccazzi A., Tonelli P., De’Angelis M. et al. Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. Pediatr. Infect. Dis. J. 2000; 19 (10): 963—967.
  44. Веселов А.В., Козлов Р.С. Цефтибутен: место в терапии инфекций. КМАХ 2006; 8 (4): 368—382.
  45. Wiseman L.R., Balfour J.A. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47 (5): 784—808.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2012
##common.cookie##